Literature DB >> 27422778

Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.

Ashley Elrick1, Sato Ashida2, Jennifer Ivanovich3, Sarah Lyons3, Barbara B Biesecker4, Melody S Goodman3, Kimberly A Kaphingst5,6.   

Abstract

Genetic test results have medical implications beyond the patient that extend to biological family members. We examined psychosocial and clinical factors associated with communication of genetic test results within families. Women (N = 1080) diagnosed with breast cancer at age 40 or younger completed an online survey; 920 women that reported prior cancer genetic testing were included in analysis. We examined the proportion of immediate family members to whom they communicated genetic test results, and built multivariable regression models to examine clinical and psychosocial variables associated with the proportion score. Participants were most likely to communicate test results to their mother (83 %) and least likely to their son (45 %). Participants who carried a BRCA mutation (OR = 1.34; 95 % CI = 1.06, 1.70), had higher interest in genomic information (OR = 1.55; 95 % CI = 1.26, 1.91) and lower genetic worry (OR = 0.91; 95 % CI = 0.86, 0.96) communicated genetic test results to a greater proportion of their immediate family members. Participants with a BRCA1/2 mutation shared their genetic test results with more male family members (OR = 1.72; 95 % CI = 1.02, 2.89). Our findings suggest that patients with high worry about genetic risks, low interest in genomic information, or receive a negative genetic test result will likely need additional support to encourage family communication.

Entities:  

Keywords:  BRCA 1/2; Breast cancer; Family communication; Genetics

Mesh:

Year:  2016        PMID: 27422778      PMCID: PMC5239754          DOI: 10.1007/s10897-016-9995-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

Review 1.  Communicating genetic risk information within families: a review.

Authors:  Mel Wiseman; Caroline Dancyger; Susan Michie
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 2.  The role of cancer worry in cancer screening: a theoretical and empirical review of the literature.

Authors:  Jennifer L Hay; Tamara R Buckley; Jamie S Ostroff
Journal:  Psychooncology       Date:  2005-07       Impact factor: 3.894

3.  The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.

Authors:  Leslie G Biesecker; James C Mullikin; Flavia M Facio; Clesson Turner; Praveen F Cherukuri; Robert W Blakesley; Gerard G Bouffard; Peter S Chines; Pedro Cruz; Nancy F Hansen; Jamie K Teer; Baishali Maskeri; Alice C Young; Teri A Manolio; Alexander F Wilson; Toren Finkel; Paul Hwang; Andrew Arai; Alan T Remaley; Vandana Sachdev; Robert Shamburek; Richard O Cannon; Eric D Green
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

4.  Behavioral health outcomes associated with religious faith and media exposure about human genetics.

Authors:  Roxanne Parrott; Kami Silk; Janice Raup Krieger; Tina Harris; Celeste Condit
Journal:  Health Commun       Date:  2004

5.  Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination.

Authors:  Shoshana Shiloh; Christopher H Wade; J Scott Roberts; Sharon Hensley Alford; Barbara B Biesecker
Journal:  Psychol Health       Date:  2012-11-05

6.  Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.

Authors:  Esme Finlay; Jill E Stopfer; Eric Burlingame; Katherine Goldfeder Evans; Katherine L Nathanson; Barbara L Weber; Katrina Armstrong; Timothy R Rebbeck; Susan M Domchek
Journal:  Genet Test       Date:  2008-03

7.  Family ties: young breast cancer patients and their children.

Authors:  Uwe Güth; Dorothy Jane Huang; Judith Alder; Rebecca Moffat
Journal:  Swiss Med Wkly       Date:  2015-08-11       Impact factor: 2.193

8.  Perceived familiarity with and importance of family health history among a medically underserved population.

Authors:  Sato Ashida; Melody S Goodman; Jewel Stafford; Christina Lachance; Kimberly A Kaphingst
Journal:  J Community Genet       Date:  2012-05-09

9.  The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.

Authors:  S R Young; Robert T Pilarski; Talia Donenberg; Charles Shapiro; Lyn S Hammond; Judith Miller; Karen A Brooks; Stephanie Cohen; Beverly Tenenholz; Damini Desai; Inuk Zandvakili; Robert Royer; Song Li; Steven A Narod
Journal:  BMC Cancer       Date:  2009-03-19       Impact factor: 4.430

10.  Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.

Authors:  Colleen M McBride; Sharon Hensley Alford; Robert J Reid; Eric B Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Genet Med       Date:  2009-08       Impact factor: 8.822

View more
  17 in total

1.  Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).

Authors:  Sherry-Ann N Brown; Hayan Jouni; Tariq S Marroush; Iftikhar J Kullo
Journal:  Circ Cardiovasc Genet       Date:  2017-08

2.  Update on multi-gene panel testing and communication of genetic test results.

Authors:  Sonya Reid; Tuya Pal
Journal:  Breast J       Date:  2020-07-08       Impact factor: 2.431

3.  Patient communication of cancer genetic test results in a diverse population.

Authors:  Charité N Ricker; Rachel B Koff; Chenxu Qu; Julie Culver; Duveen Sturgeon; Kerry E Kingham; Katrina Lowstuter; Nicolette M Chun; Courtney Rowe-Teeter; Alexandra Lebensohn; Peter Levonian; Katlyn Partynski; Karlena Lara-Otero; Christine Hong; Iva M Petrovchich; Meredith A Mills; Anne-Renee Hartman; Brian Allen; Uri Ladabaum; Kevin McDonnell; James M Ford; Stephen B Gruber; Allison W Kurian; Gregory E Idos
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

4.  Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.

Authors:  Belinda Vicuña; Harold D Delaney; Kristina G Flores; Lori Ballinger; Melanie Royce; Zoneddy Dayao; Tuya Pal; Anita Y Kinney
Journal:  J Community Genet       Date:  2017-10-02

5.  Comparing preferences for return of genome sequencing results assessed with rating and ranking items.

Authors:  Suhan Guo; Melody Goodman; Kimberly Kaphingst
Journal:  J Genet Couns       Date:  2019-10-30       Impact factor: 2.537

6.  Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Authors:  Maria I Carlo; Veda N Giri; Channing J Paller; Wassim Abida; Joshi J Alumkal; Tomasz M Beer; Himisha Beltran; Daniel J George; Elisabeth I Heath; Celestia S Higano; Rana R McKay; Alicia K Morgans; Akash Patnaik; Charles J Ryan; Edward M Schaeffer; Walter M Stadler; Mary-Ellen Taplin; Noah D Kauff; Jacob Vinson; Emmanuel S Antonarakis; Heather H Cheng
Journal:  JCO Precis Oncol       Date:  2018-08-16

7.  Impact of numeracy preferences on information needs for genome sequencing results.

Authors:  Richard D Albrechtsen; Melody S Goodman; Jemar R Bather; Kimberly A Kaphingst
Journal:  Patient Educ Couns       Date:  2020-09-25

8.  Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.

Authors:  Marleah Dean; Ann L Tezak; Sabrina Johnson; Joy K Pierce; Anne Weidner; Kate Clouse; Tuya Pal; Deborah Cragun
Journal:  Patient Educ Couns       Date:  2021-01-05

9.  Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice.

Authors:  Courtney M Studwell; Emily G Kelley; Janet S Sinsheimer; Christina G S Palmer; Kimberly LeBlanc
Journal:  J Genet Couns       Date:  2020-10-27       Impact factor: 2.537

10.  Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!

Authors:  Hikmat Abdel-Razeq
Journal:  Oncol Rev       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.